Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial
PaperCitations, authors & open-access status
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 362 citations, 2019 year and closed oa status.
362
Citations
2019
Year
closed
OA Status